Start free trial

Latest Helixmith News & Updates

See the latest news and media coverage for Helixmith. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Helixmith

Gene therapy and biopharmaceutical contract research and manufacturing company

helixmith.com
Headquarters
Seoul, South Korea
Founded year
1996
Company type
Public company
Number of employees
51–200
Industry
Pharmaceuticals

Last updated

Latest news about Helixmith

In short: Helixmith secured government funding, started a new gene therapy trial, and saw shares rise on profit hopes.

Company announcements

Helixmith

Helixmith signs MOU with Cartexell and GI Cell

The agreement, signed on April 27, 2022, at GI Cell's headquarters, focuses on joint research, development, manufacturing, and commercialization of cell and gene therapy products.

Helixmith

Helixmith announces Chinese patent for VM507 antibody

VM507 activates c-Met, shows efficacy in kidney diseases. Clinical trials planned for 2023. Potential for ischemic and neurodegenerative treatments.

Unlock all announcements with a

Media coverage

MarketScreener

News Helixmith Co., Ltd

23-02-06 Helixmith Co., Ltd announced that it expects to receive KRW 19.999986156 billion in funding from CANARIABIO M Inc. CI 22-12-28 Helixmith Co., Ltd announced...

The Korea Herald

Helixmith's Engensis phase 3 trial yields no meaningful result

Another blow to Korean bio market after SillaJen's halted Pexa-Vec trials in Aug. Helixmith shares on Korea's secondary bourse Kosdaq closed 30 percent lower at...

Unlock all articles with a

Never miss news about Helixmith

Track Helixmith and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.